bundibugyo virus bdbv species bundibugyo ebolavirus ˌbʊndiˈbʊdʒɔː taxonomic home one virus bundibugyo virus bdbv forms filamentous virions closely related infamous ebola virus ebov virus causes severe disease humans form viral hemorrhagic fever select world health organization risk group pathogen requiring biosafety level national institutes healthnational institute allergy infectious diseases category priority centers disease control prevention category bioterrorism listed biological agent export control australia species bundibugyo ebolavirus virological taxon ie manmade concept suggested included genus ebolavirus family filoviridae order species single virus member bundibugyo virus members species called bundibugyo name bundibugyo ebolavirus derived bundibugyo name chief town ugandan bundibugyo district bundibugyo virus first discovered taxonomic suffix ebolavirus denotes ebolavirus bundibugyo virus abbreviated bdbv first described single member suggested new species bundibugyo ebolavirus suggested included genus ebolavirus family filoviridae order according rules taxon naming established international committee taxonomy viruses ictv name bundibugyo ebolavirus always capitalized italicized never abbreviated preceded word species names members bundibugyo ebolaviruses capitalized italicized used without formal proposal accept species virus taxonomy submitted accepted ictv virus genus ebolavirus member species bundibugyo ebolavirus virus species bundibugyo ebolavirus bundibugyo virus properties bundibugyo ebolaviruses genome diverges prototype bundibugyo ebolavirus bundibugyo virus variant nucleotide bundibugyo virus first introduced bundibugyo ebolavirus albeit without differentiating name suggested species bundibugyo another name introduced time uganda later publications also referred virus novel strain ebola bundibugyo ebola abbreviations bebov bundibugyo ebolavirus uebov uganda briefly used bdbv established abbreviation bundibugyo bdbv one four ebolaviruses causes ebola virus disease evd humans literature also often referred ebola hemorrhagic fever ehf evd due bdbv infection differentiated evd caused ebolaviruses clinical observation clinical presentation pathology infections ebolaviruses presented together separate page see ebola virus disease bdbv made first appearance august viral hemorrhagic fever outbreak began bundibugyo kikyo townships bundibugyo district western uganda blood samples suspect cases sent us centers disease control prevention presence ebolavirus confirmed november depth analysis revealed present ebolavirus relative identical four ebolaviruses known outbreak declared february second outbreak reported august suspected infected killed including health care workers isiro pawa dungu province orientale cases confirmed reported bushmeat sept reported number cases risen confirmed probable suspected including september spread viadana total cases laboratory confirmed probable reported hautuélé district province orientale cases fatal confirmed probable healthcare workers included among probable cases suspected cases also reported press release democratic republic congo announced final tally cases confirmed probable suspect ecology bdbv currently unclear reservoir host yet identified therefore remains unclear bdbv introduced human population bats suspected harbor virus infectious marburg virus marv ravn virus ravv two distantly related filoviruses isolated traces infectious particles closely related ebola virus ebov found bats bdbv basically uncharacterized molecular level however genomic sequence genomic organization conservation individual open reading frames similar four known ebolaviruses nucleotide therefore currently assumed knowledge obtained ebov extrapolated bdbv bdbv proteins analogs ebovcitation needed united states patent multinational collaborative recognition applied published rights patent listed six different numbers including one assigned us appellation well one canadian ca two european patent office ep two world intellectual property organization wo designations openly noted deposit statement patent application section virus sample deposited cdc atlanta ga november international depository authority ida accepted method established budapest treaty international recognition deposit microorganisms purposes patent according section deposited organism also admittedly acceptable american type culture collection sample painstakingly researched led patent section patent explains purpose utility design diagnostic assays monitor ebola hf hemorrhagic fever disease humans animals develop effective antivirals vaccines avoid limiting extent reach patent section states patent published us supreme court ruled natural material could patented invention dictated trial association molecular pathology et al v myriad genetics inc et al argued decided synthetic copies natural materials could patented protected andor ruling affected patent bundibugyo strain ebola unclearcitation needed httpsenwikipediaorgwikibundibugyoebolavirus